Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses
- PMID: 40708628
- PMCID: PMC12287632
- DOI: 10.1093/ofid/ofaf395
Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses
Abstract
The emergence and re-emergence of mosquito-borne arbovirus (MBV) diseases pose a rapidly expanding global health threat fueled by the convergence of multiple ecologic, economic, and social factors, including climate change, land use, poverty, deficiencies of water storage and sanitation, and limitations of vector control programs. On December 6, 2023, the Wellcome Trust and the University of Minnesota's Center for Infectious Disease Research and Policy held a meeting titled "An integrated approach to mosquito-borne arboviruses: a priority research agenda." The meeting comprised presentations, panels, and facilitated discussions aimed at describing the state of the field, highlighting recent accomplishments, identifying novel strategies, and defining priority research goals and approaches for addressing MBV disease preparedness and response. This report summarizes meeting discussions in 3 key areas: the changing epidemiology of MBV disease, current and potential transmission- and disease-monitoring strategies, and evolutionary impacts on disease burden and transmission. It concludes with a list of priority strategies for research and investment in MBV disease prevention, preparedness, and control. To prepare for future epidemics of MBV diseases, research and policy will benefit from a multipathogen approach to MBVs. Building on existing knowledge and systems, these efforts must address social and ecological factors and connect with other global health agendas.
Keywords: disease control; disease prevention; mosquito-borne arbovirus; policy; research.
© The Author(s) 2025. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. A.K.U., A.J.M., J.O., T.L., M.T.O., E.M.L., E.S., L.L.C., R.M.F., H.S., J.W., L.Y.S., S.P.S., E.H., and K.A.M. declare Wellcome-supported participant travel to the arbovirus meeting that this manuscript summarizes. A.K.U., N.M.M., A.J.M., J.O., T.L., M.T.O., and E.M.L. report a grant from the Wellcome Trust to support planning of the arbovirus meeting and writing of the meeting report. A.M. received sponsored travel to attend the meeting that the manuscript summarizes. N.I.-E., A.C., P.F., J.G., and E.M. are employees of Wellcome. Wellcome supported organization of the meeting and its reports. L.A. is a paid adviser to Biocentis Ltd, a member of the UK Scientific Advisory Committee on Genetic Modification (Contained Use), an adviser to Synvect Inc. with equity interest, and a recipient of a Wellcome grant (number 226721/Z/22/Z). K.M. reports grants to the Pirbright Institute to support salary and research from the Biotechnology and Biological Sciences Research Council; Medical Research Council (UK); and National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH); and is a member of the Dengue Advisory Committee for the International Society for Neglected Tropical Diseases. E.H. reports NIH research support awarded to the institution. All other authors report no potential conflicts.
Figures

References
-
- Brady OJ, Hay SI. The global expansion of Dengue: how Aedes aegypti mosquitoes enabled the first pandemic arbovirus. Annu Rev Entomol 2020; 65:191–208. - PubMed
-
- Näslund J, Ahlm C, Islam K, Evander M, Bucht G, Lwande OW. Emerging mosquito-borne viruses linked to Aedes aegypti and Aedes albopictus: global status and preventive strategies. Vector Borne Zoonotic Dis 2021; 21:731–46. - PubMed